Article Text

Download PDFPDF

Chronic bronchial asthma from challenge to treatment: epidemiology and social impact
  1. Margherita Neri,
  2. Antonio Spanevello
  1. Pneumology Department, Fondazione S Maugeri, Care and Research Institute, Tradate (VA), Italy
  1. Dr M Nerimneri{at}

Statistics from

Asthma is an important cause of chronic morbidity and a crucial health problem among children and adults worldwide, with high prevalence rates particularly in many developed countries.1 2 Increasing morbidity, hospital admission rates, use of medical services, drug use and, in some countries, increasing mortality rates have been reported.3 However, controversy still exists regarding the epidemiology of asthma. There are two serious problems which need to be considered when trying to obtain reliable data on the prevalence, morbidity, and mortality of asthma. The first relates to definition; despite substantial advances in understanding the pathogenesis, genetics, and clinical characteristics of asthma, we do not have a useful definition of asthma for epidemiological purposes.2 The second problem concerns the different methods used to collect epidemiological data and information. More recently two international studies—the European Community Respiratory Health Survey (ECRHS)4 and the International Study of Asthma and Allergies in Childhood (ISAAC)5—have used the same internationally standardised questionnaire to provide important data on the prevalence of asthma.

In the ISAAC study the prevalence of symptoms in 13–14 years old subjects was highly …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.